Nutrition and food-technology programmes require clear, defensible documents that connect human evidence, safety, and claims language across multiple jurisdictions. Assignments focus on decision notes for leadership, claims feasibility assessments, targeted or systematic reviews for dossiers and publications, and safety memoranda for ingredients and finished products. Materials are written in English and calibrated to typical EU and U.S. expectations so regulatory and corporate-affairs teams can move quickly.
Claims work begins with the product goal and the intended jurisdictions. Evidence is mapped to permissible claim types, and language is calibrated accordingly—nutrition and health claims under EU rules with EFSA guidance, structure/function and qualified health claims under FDA practice, and market-specific variations where relevant. Human data are graded by hierarchy, effect direction and size are made plain, and exclusion reasons are retained so reviewers can audit the trail. Where publication strengthens credibility, manuscripts and white papers are prepared to journal instructions with consistent terminology and numbered references.
Safety and quality narratives are prepared with the same discipline. Exposure ranges, margins of safety, and uncertainty statements are set out with references to EFSA, WHO/FAO, and other authoritative sources. When needed, studies aligned to OECD test guidance or GLP are integrated with peer-reviewed literature. Key values (for example, reference doses or tolerable daily intakes) are identified and justified for use in risk characterisation. For additives, botanicals, probiotics, and novel ingredients, specific guidance and known sensitivities are flagged so formulation and labeling decisions are informed.
Evidence reviews follow protocolled steps when a formal approach is appropriate. Search strategies, screening rules, and data-extraction templates are documented; PRISMA reporting can be applied with flow diagrams and archived strategies. Quality appraisal tools are chosen to match study design, and conclusions are bounded by the strength of evidence. Figures and tables are constructed from verifiable data, legends stand alone, and supplementary files allow editors and regulators to trace values back to origin.
Operational delivery is predictable. Draft one lands on the scheduled date with tracked changes and a comment log explaining key decisions and references. One focused revision round is included. Handover includes the decision brief or report, editable vector figures, and a managed bibliography. Files integrate with document-control systems and can serve as annexes to submissions, internal governance packs, or external communications. Confidential material is handled under NDA with encrypted transfer, named-user access, and retention limited to the period specified in the statement of work.
Assignments are executed in English for organisations across Europe and beyond. Contracting and invoicing can be arranged in CHF, EUR, NOK, or DKK.